- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05952609
A 2-year Clinical Performance of Two Different Ion-releasing Bulk-fill Restorative Materials Posterior Cavities
July 11, 2023 updated by: Mansoura University
A 2-year Clinical Performance of Two Different Ion-releasing Bulk-fill Restorative Materials Placed in Posterior Cavities
The aim of this study is to evaluate and compare the clinical performance of 2 ion-releasing bulk-fill restorative materials in comparison with a bulk-fill resin composite restoration in posterior cavities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dakahlyia
-
Mansoura, Dakahlyia, Egypt, 35511
- Mansoura University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Criteria for patient's inclusion in the study will be the presence of at least 3 occlusal or proximal carious lesion in posterior teeth, favourable and stable occlusion between the remaining teeth, the patients must be older than 18 years old with permanent dentition, moderate oral hygiene, asymptomatic vital teeth with no sensitivity to percussion, and the presence of contact with adjacent teeth
Exclusion Criteria:
- Exclusion criteria will be, sever bruxism, patients with known unavailability to attend recall visits, patients with known allergy to any component of the study materials, pulp exposure during caries excavation, patients with unstable medical conditions and pregnant or lactating individuals.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1
Patients receiving Surefil One
|
Ion-releasing restoration
|
|
Experimental: Group 2
Patients receiving Cention N
|
Ion-releasing restoration
|
|
Active Comparator: Group 3
Patients receiving bulkfil resin composite
|
resin composite (No ion-release)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluating surface and marginal staining
Time Frame: 2 years
|
FDI criteria will be used
|
2 years
|
|
Evaluating fracture and retention of the materials
Time Frame: 2-years
|
FDI criteria will be used
|
2-years
|
|
Evaluating marginal adaptation and discoloration of the materials
Time Frame: 2-years
|
FDI criteria will be used
|
2-years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 10, 2021
Primary Completion (Actual)
April 15, 2023
Study Completion (Actual)
May 15, 2023
Study Registration Dates
First Submitted
July 11, 2023
First Submitted That Met QC Criteria
July 11, 2023
First Posted (Actual)
July 19, 2023
Study Record Updates
Last Update Posted (Actual)
July 19, 2023
Last Update Submitted That Met QC Criteria
July 11, 2023
Last Verified
April 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- M02060421
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Secondary Caries
-
Jouf UniversityCompletedSecondary CariesSaudi Arabia
-
Federal University of PelotasActive, not recruiting
-
Radboud University Medical CenterCompletedSecondary Caries
-
Cairo UniversityUnknown
-
Cairo UniversityRecruitingSecondary Caries Around Resin Composite RestorationsEgypt
-
Mansoura UniversityRecruitingSecondary Caries Dental Restoration Failure of Marginal IntegrityEgypt
-
Cairo UniversityNot yet recruiting
-
Universidade Federal do Rio de JaneiroUnknownDental Caries | Secondary Dental CariesBrazil
-
Khon Kaen UniversityNational Institutes of Health (NIH); Fogarty International Center of the National...CompletedDental Caries | Personal Satisfaction | Secondary Dental CariesThailand
-
University of Health Sciences LahoreNot yet recruitingIndirect Pulp CapPakistan
Clinical Trials on Surefil One
-
Nourhan M.AlyCompletedClass II Dental CariesEgypt
-
Dentsply Sirona Implants and ConsumablesTerminated
-
Misr International UniversityRecruiting
-
Minia UniversityRecruiting
-
Cairo UniversityNot yet recruiting
-
King Abdullah University HospitalJordan University of Science and TechnologyCompletedDental Restorations, PermanentJordan
-
Hacettepe UniversityCompleted
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
-
Harran UniversityCompletedPost Operative Pain | Chronic Apical Periodontitis of Pulpal OriginTurkey (Türkiye)
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Moroccans | Advance Medical Directives | Muslims | Living WillBelgium